A chipmaking machine etches and coats a wafer inside a sealed chamber. It only works if the pressure, gas flow and plasma are exactly right. MKS makes the parts that control them.
The company · 2 · What exactly does it sell?
Three divisions of similar size
Each $1 of sales, June quarter
41%32%27%
Pressure, gas and power controlsPlating chemistryLasers and optics
Machine makers buy its parts to build new machines, and chip factories buy its chemicals every week to keep running. No single customer is 10% of sales.
The company · 3 · How does it make money?
Each extra dollar of sales keeps 44 cents as profit
44 centskept from each extra dollar of sales
27.8 centsprofit per sales dollar last quarter
81%of sales come from outside America
Research and selling costs rise slower than sales, so each new dollar costs less to win. That works in reverse too: in a flat year the gain turns around.
Is it a good business? · 4 · What gives it an edge?
Once a recipe is approved, its part cannot be swapped
Top 10
for service in TechInsights' survey of 1,201 responses
Advanced Energy
a rival, absent from that same top ten
A chipmaker picks the part at the start of a machine design, and its copy-exact rules forbid swapping it later, which would risk ruining wafers. So MKS keeps the slot for the life of the design.
Is it a good business? · 5 · What is the catch?
Rivals chase single pieces, and one purchase hurt
Advanced Energychasing share in power supplies for etching
Qnitysells the same plating chemistry to the same buyers
No single rival matches all it sells; the danger is a customer approving a second supplier for one part. Its 2022 purchase of Atotech was largely written down a year later.
Is it a good business? · 6 · What does its record show?
Record sales, and running costs barely moved
Sales, $B
3.0
3.5
3.6
3.6
3.9
4.8
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales, latest quarter+43%to a record $1.41B
Costs against sales$6Mmore running cost, on $165M more sales
Repeat sales+26%chip factory chemicals
Sales were flat from 2022 to 2024, then rose with AI chip spending. In the 2019 downturn sales fell 8.4%, which shows what a flat year can do.
Is it a good business? · 7 · How much room is there to grow?
Chip equipment spending keeps rising
$133Bforecast spending on chip equipment in 2026
$151Bforecast for 2027
$8Bwhat MKS says it could sell into chipmaking
Against that $8B, MKS sells about $2.22B to chipmakers today. These forecasts come from the industry body SEMI and can be cut quickly when chipmakers pause.
Is it a good business? · 8 · Who is in charge?
A chief still paying down one costly purchase
Since 2020John Lee as chief executive
Atotechbought, then largely written down a year later
Well under 1%owned by insiders, none bought this year
The bonus pays on profit and on cutting debt. Share awards depend on profit per share and beating similar companies' shares.
The story right now · 9 · Why is chip equipment selling so well?
AI needs more chips, so chipmakers buy more machines
$133Bchip equipment spending forecast for 2026
$1.41BMKS's record third-quarter sales
54.2% belowthe shares against their June high
AI data centres need advanced chips, so chipmakers are building new factories full of machines. Each machine carries MKS parts. Chip spending has always run in waves, rising fast and then pausing.
The story right now · 10 · Why does profit swing so much?
When costs stay put, profit swings far more than sales
Sales rise 13%Factories and staff are already paid for.
Costs rise 2%Most of the extra sales are profit.
Sales go flatThe same costs must still be paid.
Profit shrinks fastThe gain runs in reverse.
This is why chip suppliers' profits rise and fall so sharply. Our estimate assumes most of today's jump lasts; the risk is a pause in chip spending.
The story right now · 11 · What changed lately?
Record sales, and costs held almost still
+43%sales, to a record $1.41B
$6Mmore running costs on $165M more sales
+26%chip factory chemicals
$500Mof its own shares it will buy back
Strong quarter
The cost test was answered: costs rose 2% on 13% more sales. One quarter at a spending peak cannot show the profit survives a downturn.
The story right now · 12 · What is everyone arguing about?
Is the profit jump built in, or a spending peak?
Many investors think
An AI winner whose profit per share more than doubles by 2027
We think
Fixed costs meeting a spending peak, which the price already counts on
Twelve analysts asked 28 questions on the call and none asked about costs if sales stop rising. We are wrong, happily, if profit holds into 2027 with costs flat.
The price and our view · 13 · What is a share worth?
The price sits about a third below our value
$335what we think a share is worth · the last close is of that
$335our value
Attractive below $268
Neutral
Unattractive above $402
$151gloomy: growth halves and profit per sale slips
$335our estimate: experts' forecasts, then slowing
$463sunny: growth runs a quarter faster
Value per share in three futures. None is a prediction of the share price.
We estimate what a share is worth from the cash the business should earn over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.
The price and our view · 14 · How could we be wrong?
The chip cycle turns, and orders can vanish
The cycle turnsBiggest
MKS outgrows chip spending early, and falls harder later.
Orders that vanishWatch
Cancelled with little penalty; only one quarter forecast.
Selling abroadWatch
81% of sales come from outside America.
Costs in a flat yearUnknown
Nobody has asked whether costs stay flat.
A 2023 write-down of a past purchase once pushed its profit deep below zero.
The price and our view · 15 · How will we know?
February shows whether the cost discipline is built in
Running costs stay near $288M as sales reach $1.49BGood sign
Chemistry keeps growing beside the machine partsGood sign
Fourth-quarter results and the annual report. Companies report every three months; each report is a test of the story.
Our view also changes on price alone: if the shares rise to within a fifth of our estimate, the cushion is gone and we move to Neutral.
The price and our view · 16 · So, what do we think?
Chip-machine parts whose profit jumped as costs stood still
$335our value
Attractive below $268
Neutral
Unattractive above $402
AttractiveMedium conviction
MKS holds its slot in the machines for years, and its profit jumped as costs stood still. The price is well below our estimate. Conviction is Medium because a pause in chip spending would reverse the jump.
↑ ↓ to move · C for contents
What it does
More about the company
Who it is
A chipmaking machine etches and coats a wafer inside a sealed chamber, and it only works if the pressure, the gas flow and the plasma are exactly right. MKS makes the gauges, valves and power supplies that control them, sold to the companies that build the machines.
It also sells lasers and optics for inspection tools, and the chemistry and machines that plate copper onto circuit boards and chip packages. No single rival competes with it across all of that.
How it makes money
Machine builders buy MKS parts for every tool they ship, so semiconductor sales, $554M of the June quarter's $1.25B, rise and fall with spending on new chip factories, and orders can be cancelled with little penalty. On the plating side, each machine sold is meant to pull repeat sales of the chemistry it uses.
Growth and profit
What growth costs
Today's MKS gets more profitable as it grows: research and selling costs rise more slowly than sales, so each new dollar of sales costs less to win. Over five years those costs rose as a share of sales, but that was the chemistry business it bought, not waste. A flat year turns the effect around.
Its record
The numbers
Is it growing?Steady
Sales grew 25% over the twelve months to Sep 2026, faster than the 9.6% in the year to Dec 2025.
Is it profitable?Healthy
Operating margin is 18%, up from −43% in the year to Dec 2023.
Does growth pay off?Pays off
Running costs take 29¢ of each sales dollar, up from 23¢ in the year to Dec 2021.
Does it earn good returns?Decent
Each dollar put into the business earns 11% a year after tax, down from 17% in the year to Dec 2021.
Is it making cash?Solid
It turned 12% of sales into free cash, $552M over the last twelve months.
Is the balance sheet safe?Strained
It owes $3.27B more than the cash it holds, about 4.5 years of the cash its operations bring in.
Are shares being diluted?Diluting
The share count rose 30% in 4.8 years, and pay in shares costs 1.2% of sales.
Why it wins
The evidence
The chipmaker, not the machine builder, picks the part. Once a production recipe is approved around a particular gauge or generator, the factory's rule of copying exactly forbids swapping it without re-approving the process. So MKS wins at the start of a machine design and keeps the slot for its life.
Outsiders back this up: 1,201 chipmaker survey responses put it in the top ten large suppliers for service. And no customer is more than 10% of sales.
Who could beat it
The rivals in full
Advanced Energy's own annual report says it is chasing more share in one kind of etching, the application where MKS claims to lead. In plating chemistry, Qnity, spun out of DuPont in November 2025, sells the same product to the same buyers, and Element Solutions names MKS as its most significant competitor.
Each rival
Advanced Energy IndustriesAEIS
The radio-frequency generator and matching network inside a dielectric etch tool - the application MKS's own Q2 2026 call names as a segment share leadership position.
The electroless and electrolytic copper plating chemistry a substrate maker buys to metallise an IC substrate, which is what the Materials Solutions Division sells.
The same plating and surface-finishing chemistry sold to printed circuit board fabricators, where ESI's own annual report names MKS Instruments as its most significant competitor.
How big it could get
The market and who has signed
The market
Chipmakers are forecast to spend $133B on equipment for the largest wafers in 2026, up 18%, and $151B in 2027. MKS says its parts can go into tools making up over 85% of that, but puts what it can actually sell into semiconductors at $8B. Its own semiconductor sales run at about $2.22B a year.
Who runs it
Leaders, pay and the cash
Who runs it
John Lee has run MKS since 2020, after joining in 2007. He bought Atotech, wrote much of it down a year later, and has spent the time since paying down the debt it left. Ramakumar Mayampurath has run finance since 2024. Insiders own well under 1% of the company and none has bought shares on the market in the past year. The bonus pays on adjusted operating profit and on cutting debt; the share awards on adjusted earnings and on beating similar companies' shares.
What they did with the money
It has been paying down debt, prepaying $1.27B of term loan in February and $100M in each of May and August. But it also owes $1.4B of bonds that can be swapped for shares: above $237.42 a share, about 13 cents of every further dollar of gain goes to their holders.
The last report
The latest report
MKS's Q3 sales rose 43% to a record $1.41B and costs barely moved
What it did to the thesis Strong quarter
It supported the cost-discipline half of the case: costs barely moved while sales jumped. The call showed the consumables the machines pull in growing, which helps the second half, though slower than the machines themselves. One peak-cycle quarter cannot show the margin survives a downturn.
The report
The third quarter of 2026 beat the company's forecast on every line. Sales rose 43% to $1.41B, packaging grew 9% when a flat quarter was guided, and the operating margin reached 27.8%.
Operating costs rose only $6M from the second quarter while sales rose $165M, so about 44 cents of each added dollar became profit. MKS guided $1.49B for the next quarter and announced a $500M buyback. On the call it said consumable chemicals grew 26%, almost all from older machines, and that new machines will add to it over the next two years.
What's happening now
The background
The shares are 54.2% below their June high and 22.7% below where we first priced them, even as sales set a record.
Q3, reported 4 November, answered the cost test: costs rose 2% on 13% more sales. The call on 5 November should show whether chemistry is growing too, and what the Ophir sale means.
Where we disagree
Both sides in full
The market
An artificial-intelligence compounder: most analysts rate it Buy and expect adjusted earnings a share to more than double between 2025 and 2027.
We believe
The profit jump looks mostly like fixed costs meeting a spending peak; Q3 and the Q4 guide fit a lasting change too, and the price counts on the peak lasting.
The argument
The market is reading the headline margin. The call explained it, yet twelve analysts asked 28 questions there and not one asked what happens to costs if sales stop rising.
We would be wrong if gross margin holds near 47% into 2027 while costs stay flat. Q3 and the Q4 guide of 47.5% with costs near $288M point that way; 2027 is the test.
What it's worth
How we value it
Valued on the analysts' revenue path for three years, each later year closing 30% of the gap to 4%, on official operating profit with stock pay a cost and tax paid in full; the thesis's own evidence is the check on that path.
What the price assumes
Sales growth in the first year, then slowing as ours does, at the same profit per sale.
The price assumed
-0.7%
Our estimate
22%
Measured at the close of
6 Nov 2026
The three cases
Bear case$151
Growth runs at half the analysts' path, 11% and 6%, the margin settles a fifth lower at 20.9%, and new capital earns only the 8% rate: the downturn test.
Our value$335
Revenue grows 22% and 13% over three years, the analysts' path (C56), then fades toward 4%, closing 30% of the gap each year; the margin moves to 26.2%, the analysts' year-three figure after stock pay.
Bull case$463
Growth runs a quarter above the analysts' path, 28% and 16%, the margin reaches 28.8%, and new capital earns 15%.
What could go wrong
Every risk
The risks
The cycle turns
The chief executive says MKS outgrows chip spending early in an upswing and that it reverses in the downturn. Revenue fell 8.4% in 2019.
Orders that can vanish
Semiconductor orders can be cancelled or rescheduled with little penalty, and MKS guides only one quarter ahead.
Acquisitions on the books
Past purchases make up 51% of its assets, and a 2023 write-down pushed the operating margin to minus 42.9%.
Selling abroad
81% of revenue comes from outside America, concentrated in China, South Korea, Singapore, Taiwan and Japan, with the export-control and tariff risk that carries.
What we still do not know
Whether operating costs stay flat once sales stop rising. Nobody on the call asked.
Whether chemistry sales will follow the plating machines. Chemistry grew about 21%, against 43.2% for that whole business.
Whether a customer will approve a second supplier in the etching work MKS leads, where Advanced Energy is chasing share.
What changes our view
Every route to a new view
Every route to a new view
→ Neutral
The share price rises to about $268, 80% of what we think the business is worth, so it is no longer cheap enough.
→ Unattractive
The share price rises to about $402, 20% above what we think the business is worth.
→ Unattractive
The industry body SEMI cuts its 2027 chip-equipment spending forecast below the 2026 figure. A customer approves a second supplier for a part MKS calls its own.
The next test
It supports the case if
Non-GAAP operating expenses at or below $293M, gross margin at or above 47.0% and non-GAAP operating margin at or above 28%, with Electronics & Packaging revenue at or above $415M.
It pressures the case if
Non-GAAP operating expenses above $295M, or gross margin below 46%, or Electronics & Packaging revenue below $400M, any of which says the leverage was volume rather than structure.
We would also be wrong if
Operating costs rise as fast as revenue for two quarters running.
The verdict
Scores and how we weighed it
The scores
Growth
3 of 4
Business quality
3 of 4
Financial position
3 of 4
Execution record
3 of 4
Per share capture
2 of 4
Potential
2 of 4
Risk profile
3 of 4
Valuation
4 of 4
Evidence quality
3 of 4
How we weighed it
ValuePositive
The price is a little over half our value on the analysts' path, though the bear case sits below it.
BusinessMixed
Good parts inside chipmaking machines, but profit swings with the cycle and past purchases weigh on the books.
GrowthPositive
Profit rose far faster than sales because costs stayed flat, and the price asks little more growth than that.
RisksNegative
The cycle can turn, orders can be cancelled cheaply, most sales are abroad, and a downturn would test the cost base.
RivalsMixed
It is only a little dearer than its filed rivals, and the whole group is dear, so its level is the group's.
The groupMixed
Chip equipment names move together on spending news; the cost discipline is its own fact.
Latest newsPositive
The latest report showed costs barely moving while sales jumped and consumables growing; one strong quarter cannot prove the downturn.
In plain words
Our estimate of value
We forecast how much cash the business can earn over the next ten years and beyond, then ask what that stream is worth today to an investor who wants an 8% yearly return. We do it three times: a gloomy future, an expected one and a sunny one. We call a share Attractive only when its price is at least 20% below the expected estimate, and Unattractive when it is 20% above.